|
US6010613A
(en)
*
|
1995-12-08 |
2000-01-04 |
Cyto Pulse Sciences, Inc. |
Method of treating materials with pulsed electrical fields
|
|
EP0938674B1
(de)
|
1996-11-16 |
2005-06-01 |
NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen in Reutlingen Stiftung Bürgerlichen Rechts |
Mikroelementenanordnung, verfahren zum kontaktieren von in einer flüssigen umgebung befindlichen zellen und verfahren zum herstellen einer mikroelementenanordnung
|
|
EP1003847A4
(de)
*
|
1997-09-04 |
2005-04-06 |
Science Res Lab Inc |
Zelltrennung mittels elektrischer felder
|
|
AU733053C
(en)
|
1998-02-24 |
2001-11-29 |
Boston Scientific Limited |
High flow rate dialysis catheters and related methods
|
|
DE19827957C2
(de)
*
|
1998-05-27 |
2000-06-29 |
Micronas Intermetall Gmbh |
Verfahren und Vorrichtung zur Messung einer Zustandsgröße
|
|
DE19841337C1
(de)
|
1998-05-27 |
1999-09-23 |
Micronas Intermetall Gmbh |
Verfahren und Vorrichtung zur intrazellulären Manipulation einer biologischen Zelle
|
|
WO1999064581A1
(en)
|
1998-06-10 |
1999-12-16 |
University Of South Florida |
Electrofusion chamber
|
|
GB9812519D0
(en)
*
|
1998-06-10 |
1998-08-05 |
Immunoporation Ltd |
Treating cells
|
|
GB9812783D0
(en)
|
1998-06-12 |
1998-08-12 |
Cenes Ltd |
High throuoghput screen
|
|
JP2002522029A
(ja)
|
1998-07-27 |
2002-07-23 |
ジェネンテック・インコーポレーテッド |
コートタンパク質の改変によるファージ提示における改良した形質転換効率
|
|
GB9908681D0
(en)
*
|
1999-04-16 |
1999-06-09 |
Central Research Lab Ltd |
Apparatus for, and method of, introducing a substance into an object
|
|
US6387671B1
(en)
|
1999-07-21 |
2002-05-14 |
The Regents Of The University Of California |
Electrical impedance tomography to control electroporation
|
|
US6300108B1
(en)
|
1999-07-21 |
2001-10-09 |
The Regents Of The University Of California |
Controlled electroporation and mass transfer across cell membranes
|
|
US6927049B2
(en)
*
|
1999-07-21 |
2005-08-09 |
The Regents Of The University Of California |
Cell viability detection using electrical measurements
|
|
US6403348B1
(en)
|
1999-07-21 |
2002-06-11 |
The Regents Of The University Of California |
Controlled electroporation and mass transfer across cell membranes
|
|
US7053063B2
(en)
*
|
1999-07-21 |
2006-05-30 |
The Regents Of The University Of California |
Controlled electroporation and mass transfer across cell membranes in tissue
|
|
EP1254951B1
(de)
*
|
2000-01-27 |
2011-01-12 |
The Mollennium Laboratories |
Molekültransferierende vorrichtung, zusatz für molekültransferierende vorrrichtung und molekül-transferierendes verfahren
|
|
US6795728B2
(en)
|
2001-08-17 |
2004-09-21 |
Minnesota Medical Physics, Llc |
Apparatus and method for reducing subcutaneous fat deposits by electroporation
|
|
US6892099B2
(en)
*
|
2001-02-08 |
2005-05-10 |
Minnesota Medical Physics, Llc |
Apparatus and method for reducing subcutaneous fat deposits, virtual face lift and body sculpturing by electroporation
|
|
US6697670B2
(en)
*
|
2001-08-17 |
2004-02-24 |
Minnesota Medical Physics, Llc |
Apparatus and method for reducing subcutaneous fat deposits by electroporation with improved comfort of patients
|
|
US8251986B2
(en)
|
2000-08-17 |
2012-08-28 |
Angiodynamics, Inc. |
Method of destroying tissue cells by eletroporation
|
|
US6994706B2
(en)
|
2001-08-13 |
2006-02-07 |
Minnesota Medical Physics, Llc |
Apparatus and method for treatment of benign prostatic hyperplasia
|
|
USRE42016E1
(en)
|
2001-08-13 |
2010-12-28 |
Angiodynamics, Inc. |
Apparatus and method for the treatment of benign prostatic hyperplasia
|
|
US7130697B2
(en)
*
|
2002-08-13 |
2006-10-31 |
Minnesota Medical Physics Llc |
Apparatus and method for the treatment of benign prostatic hyperplasia
|
|
DE60226501D1
(de)
*
|
2001-08-31 |
2008-06-19 |
Cyto Pulse Sciences Inc |
Dielektrophoresewellenform mit nichtlinearer amplitude zur zellfusion
|
|
JP4567337B2
(ja)
*
|
2001-12-06 |
2010-10-20 |
バイオ−ラッド ラボラトリーズ,インコーポレイティド |
メンブレン式融合を促進する電気穿孔キュベット用インサート
|
|
DE10202094B4
(de)
|
2002-01-21 |
2006-09-28 |
Eppendorf Ag |
Verfahren und Vorrichtung zur Elektroporation biologischer Zellen
|
|
US20060068495A1
(en)
*
|
2002-02-22 |
2006-03-30 |
Justin Tessie |
Process of cell electrofusion
|
|
KR100859715B1
(ko)
*
|
2002-07-16 |
2008-09-23 |
독립행정법인농업생물자원연구소 |
감압/가압을 이용한 일렉트로포레이션용 기구
|
|
EP2359689B1
(de)
|
2002-09-27 |
2015-08-26 |
The General Hospital Corporation |
Mikrofluid-Vorrichtung zur Zelltrennung, sowie Verwendung derselben
|
|
WO2004031353A2
(en)
*
|
2002-09-30 |
2004-04-15 |
Maxcyte, Inc. |
Apparatus and method for streaming electroporation
|
|
US8298222B2
(en)
*
|
2003-12-24 |
2012-10-30 |
The Regents Of The University Of California |
Electroporation to deliver chemotherapeutics and enhance tumor regression
|
|
EP1696812B1
(de)
|
2003-12-24 |
2015-07-22 |
The Regents of The University of California |
Gewebeablation mit irreversibler elektroporation
|
|
JP4443278B2
(ja)
*
|
2004-03-26 |
2010-03-31 |
テルモ株式会社 |
拡張体付カテーテル
|
|
AU2005250369A1
(en)
*
|
2004-05-18 |
2005-12-15 |
Genentech, Inc. |
M13 virus major coat protein variants for C-terminal and BI-terminal display of a heterologous protein
|
|
WO2006098430A1
(ja)
*
|
2005-03-17 |
2006-09-21 |
Kyoto University |
細胞内物質導入装置、細胞クランプ装置及び流路の形成方法
|
|
US20070196820A1
(en)
|
2005-04-05 |
2007-08-23 |
Ravi Kapur |
Devices and methods for enrichment and alteration of cells and other particles
|
|
US20060264752A1
(en)
*
|
2005-04-27 |
2006-11-23 |
The Regents Of The University Of California |
Electroporation controlled with real time imaging
|
|
EP2270130B1
(de)
|
2005-06-13 |
2020-04-29 |
Tosoh Corporation |
Zellfusionsvorrichtung und Verfahren zur Zellfusion unter Verwendung derselben
|
|
US20060293730A1
(en)
|
2005-06-24 |
2006-12-28 |
Boris Rubinsky |
Methods and systems for treating restenosis sites using electroporation
|
|
US8114070B2
(en)
|
2005-06-24 |
2012-02-14 |
Angiodynamics, Inc. |
Methods and systems for treating BPH using electroporation
|
|
US20060293731A1
(en)
*
|
2005-06-24 |
2006-12-28 |
Boris Rubinsky |
Methods and systems for treating tumors using electroporation
|
|
US20060293725A1
(en)
*
|
2005-06-24 |
2006-12-28 |
Boris Rubinsky |
Methods and systems for treating fatty tissue sites using electroporation
|
|
US8214221B2
(en)
*
|
2005-06-30 |
2012-07-03 |
Lg Electronics Inc. |
Method and apparatus for decoding an audio signal and identifying information included in the audio signal
|
|
US8921102B2
(en)
|
2005-07-29 |
2014-12-30 |
Gpb Scientific, Llc |
Devices and methods for enrichment and alteration of circulating tumor cells and other particles
|
|
US20070105206A1
(en)
*
|
2005-10-19 |
2007-05-10 |
Chang Lu |
Fluidic device
|
|
US20070156135A1
(en)
*
|
2006-01-03 |
2007-07-05 |
Boris Rubinsky |
System and methods for treating atrial fibrillation using electroporation
|
|
US7674249B2
(en)
|
2006-10-16 |
2010-03-09 |
The Regents Of The University Of California |
Gels with predetermined conductivity used in electroporation of tissue
|
|
US20080132884A1
(en)
*
|
2006-12-01 |
2008-06-05 |
Boris Rubinsky |
Systems for treating tissue sites using electroporation
|
|
US8796021B2
(en)
|
2007-02-23 |
2014-08-05 |
Advanced Cell Technology, Inc. |
Blastomere culture to produce mammalian embryonic stem cells
|
|
US20100004623A1
(en)
*
|
2008-03-27 |
2010-01-07 |
Angiodynamics, Inc. |
Method for Treatment of Complications Associated with Arteriovenous Grafts and Fistulas Using Electroporation
|
|
US20090248012A1
(en)
*
|
2008-03-27 |
2009-10-01 |
The Regents Of The University Of California |
Irreversible electroporation device and method for attenuating neointimal
|
|
US11254926B2
(en)
|
2008-04-29 |
2022-02-22 |
Virginia Tech Intellectual Properties, Inc. |
Devices and methods for high frequency electroporation
|
|
US9198733B2
(en)
|
2008-04-29 |
2015-12-01 |
Virginia Tech Intellectual Properties, Inc. |
Treatment planning for electroporation-based therapies
|
|
US10238447B2
(en)
|
2008-04-29 |
2019-03-26 |
Virginia Tech Intellectual Properties, Inc. |
System and method for ablating a tissue site by electroporation with real-time monitoring of treatment progress
|
|
US9598691B2
(en)
|
2008-04-29 |
2017-03-21 |
Virginia Tech Intellectual Properties, Inc. |
Irreversible electroporation to create tissue scaffolds
|
|
US8992517B2
(en)
|
2008-04-29 |
2015-03-31 |
Virginia Tech Intellectual Properties Inc. |
Irreversible electroporation to treat aberrant cell masses
|
|
US10702326B2
(en)
|
2011-07-15 |
2020-07-07 |
Virginia Tech Intellectual Properties, Inc. |
Device and method for electroporation based treatment of stenosis of a tubular body part
|
|
US10117707B2
(en)
|
2008-04-29 |
2018-11-06 |
Virginia Tech Intellectual Properties, Inc. |
System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies
|
|
US10245098B2
(en)
|
2008-04-29 |
2019-04-02 |
Virginia Tech Intellectual Properties, Inc. |
Acute blood-brain barrier disruption using electrical energy based therapy
|
|
US9867652B2
(en)
|
2008-04-29 |
2018-01-16 |
Virginia Tech Intellectual Properties, Inc. |
Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds
|
|
US10272178B2
(en)
|
2008-04-29 |
2019-04-30 |
Virginia Tech Intellectual Properties Inc. |
Methods for blood-brain barrier disruption using electrical energy
|
|
US9283051B2
(en)
|
2008-04-29 |
2016-03-15 |
Virginia Tech Intellectual Properties, Inc. |
System and method for estimating a treatment volume for administering electrical-energy based therapies
|
|
US11272979B2
(en)
|
2008-04-29 |
2022-03-15 |
Virginia Tech Intellectual Properties, Inc. |
System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies
|
|
WO2009137800A2
(en)
|
2008-05-09 |
2009-11-12 |
Angiodynamics, Inc. |
Electroporation device and method
|
|
WO2009155526A2
(en)
|
2008-06-20 |
2009-12-23 |
Angiodynamics, Inc. |
Device and method for the ablation of fibrin sheath formation on a venous catheter
|
|
US9681909B2
(en)
|
2008-06-23 |
2017-06-20 |
Angiodynamics, Inc. |
Treatment devices and methods
|
|
US20100152725A1
(en)
*
|
2008-12-12 |
2010-06-17 |
Angiodynamics, Inc. |
Method and system for tissue treatment utilizing irreversible electroporation and thermal track coagulation
|
|
US8753335B2
(en)
|
2009-01-23 |
2014-06-17 |
Angiodynamics, Inc. |
Therapeutic energy delivery device with rotational mechanism
|
|
WO2010093692A2
(en)
|
2009-02-10 |
2010-08-19 |
Hobbs Eamonn P |
Irreversible electroporation and tissue regeneration
|
|
US8632534B2
(en)
|
2009-04-03 |
2014-01-21 |
Angiodynamics, Inc. |
Irreversible electroporation (IRE) for congestive obstructive pulmonary disease (COPD)
|
|
WO2010118387A1
(en)
|
2009-04-09 |
2010-10-14 |
Virginia Tech Intellectual Properties, Inc. |
Integration of very short electric pulses for minimally to noninvasive electroporation
|
|
US11382681B2
(en)
|
2009-04-09 |
2022-07-12 |
Virginia Tech Intellectual Properties, Inc. |
Device and methods for delivery of high frequency electrical pulses for non-thermal ablation
|
|
US11638603B2
(en)
|
2009-04-09 |
2023-05-02 |
Virginia Tech Intellectual Properties, Inc. |
Selective modulation of intracellular effects of cells using pulsed electric fields
|
|
USD630321S1
(en)
|
2009-05-08 |
2011-01-04 |
Angio Dynamics, Inc. |
Probe handle
|
|
WO2010138919A2
(en)
|
2009-05-28 |
2010-12-02 |
Angiodynamics, Inc. |
System and method for synchronizing energy delivery to the cardiac rhythm
|
|
US9895189B2
(en)
|
2009-06-19 |
2018-02-20 |
Angiodynamics, Inc. |
Methods of sterilization and treating infection using irreversible electroporation
|
|
US20110118732A1
(en)
|
2009-11-19 |
2011-05-19 |
The Regents Of The University Of California |
Controlled irreversible electroporation
|
|
US9816086B2
(en)
*
|
2010-07-06 |
2017-11-14 |
The Ohio State University |
Dose and location controlled drug/gene/particle delivery to individual cells by nanoelectroporation
|
|
EP2627274B1
(de)
|
2010-10-13 |
2022-12-14 |
AngioDynamics, Inc. |
System zur elektrischen ableitung des gewebes eines patienten
|
|
WO2012088149A2
(en)
|
2010-12-20 |
2012-06-28 |
Virginia Tech Intellectual Properties, Inc. |
High-frequency electroporation for cancer therapy
|
|
US9382510B2
(en)
|
2011-08-25 |
2016-07-05 |
Jian Chen |
Methods and devices for electroporation
|
|
US9078665B2
(en)
|
2011-09-28 |
2015-07-14 |
Angiodynamics, Inc. |
Multiple treatment zone ablation probe
|
|
US9414881B2
(en)
|
2012-02-08 |
2016-08-16 |
Angiodynamics, Inc. |
System and method for increasing a target zone for electrical ablation
|
|
US9888956B2
(en)
|
2013-01-22 |
2018-02-13 |
Angiodynamics, Inc. |
Integrated pump and generator device and method of use
|
|
US10166321B2
(en)
|
2014-01-09 |
2019-01-01 |
Angiodynamics, Inc. |
High-flow port and infusion needle systems
|
|
AU2015259303B2
(en)
|
2014-05-12 |
2021-10-28 |
Arena, Christopher B. |
Selective modulation of intracellular effects of cells using pulsed electric fields
|
|
US12114911B2
(en)
|
2014-08-28 |
2024-10-15 |
Angiodynamics, Inc. |
System and method for ablating a tissue site by electroporation with real-time pulse monitoring
|
|
EP3194581A4
(de)
|
2014-09-15 |
2018-04-25 |
Children's Medical Center Corporation |
Verfahren und zusammensetzungen zur erhöhung der somatischen zellkerntransfer(scnt)-effizienz durch entfernung der histon h3-lysin-trimethylierung
|
|
US10694972B2
(en)
|
2014-12-15 |
2020-06-30 |
Virginia Tech Intellectual Properties, Inc. |
Devices, systems, and methods for real-time monitoring of electrophysical effects during tissue treatment
|
|
US10660691B2
(en)
|
2015-10-07 |
2020-05-26 |
Angiodynamics, Inc. |
Multiple use subassembly with integrated fluid delivery system for use with single or dual-lumen peristaltic tubing
|
|
US11390840B2
(en)
*
|
2016-09-30 |
2022-07-19 |
University Of Florida Research Foundation, Inc. |
Systems and methods including porous membrane for low-voltage continuous cell electroporation
|
|
US10905492B2
(en)
|
2016-11-17 |
2021-02-02 |
Angiodynamics, Inc. |
Techniques for irreversible electroporation using a single-pole tine-style internal device communicating with an external surface electrode
|
|
US11043823B2
(en)
*
|
2017-04-06 |
2021-06-22 |
Tesla, Inc. |
System and method for facilitating conditioning and testing of rechargeable battery cells
|
|
CR20200251A
(es)
|
2017-11-17 |
2020-07-17 |
Iovance Biotherapeutics Inc |
Expansión de til de aspirados con aguja fina y biopsias por punción
|
|
EP3714041A1
(de)
|
2017-11-22 |
2020-09-30 |
Iovance Biotherapeutics, Inc. |
Expansion von peripheren blutlymphozyten (pbls) aus peripherem blut
|
|
US11607537B2
(en)
|
2017-12-05 |
2023-03-21 |
Virginia Tech Intellectual Properties, Inc. |
Method for treating neurological disorders, including tumors, with electroporation
|
|
US12390262B2
(en)
|
2018-03-13 |
2025-08-19 |
Virginia Tech Intellectual Properties, Inc. |
Treatment planning system for immunotherapy enhancement via non-thermal ablation
|
|
US11925405B2
(en)
|
2018-03-13 |
2024-03-12 |
Virginia Tech Intellectual Properties, Inc. |
Treatment planning system for immunotherapy enhancement via non-thermal ablation
|
|
US11311329B2
(en)
|
2018-03-13 |
2022-04-26 |
Virginia Tech Intellectual Properties, Inc. |
Treatment planning for immunotherapy based treatments using non-thermal ablation techniques
|
|
WO2019210131A1
(en)
|
2018-04-27 |
2019-10-31 |
Iovance Biotherapeutics, Inc. |
Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy
|
|
IT201800006914A1
(it)
*
|
2018-07-04 |
2020-01-04 |
|
Dispositivo di caratterizzazione elettrica di costrutti cellulari
|
|
US12611427B2
(en)
|
2018-11-05 |
2026-04-28 |
Iovance Biotherapeutics, Inc. |
Treatment of NSCLC patients refractory for anti-PD-1 antibody
|
|
JP7854297B2
(ja)
|
2018-11-05 |
2026-05-01 |
アイオバンス バイオセラピューティクス,インコーポレイテッド |
改良された腫瘍反応性t細胞の選択
|
|
WO2020096927A1
(en)
|
2018-11-05 |
2020-05-14 |
Iovance Biotherapeutics, Inc. |
Expansion of tils utilizing akt pathway inhibitors
|
|
MY210603A
(en)
|
2018-11-05 |
2025-10-01 |
Iovance Biotherapeutics Inc |
Processes for production of tumor infiltrating lymphocytes and uses of the same in immunotherapy
|
|
CA3123392A1
(en)
|
2018-12-19 |
2020-06-25 |
Iovance Biotherapeutics, Inc. |
Methods of expanding tumor infiltrating lymphocytes using engineered cytokine receptor pairs and uses thereof
|
|
WO2020180733A1
(en)
|
2019-03-01 |
2020-09-10 |
Iovance Biotherapeutics, Inc. |
Expansion of tumor infiltrating lymphocytes from liquid tumors and therapeutic uses thereof
|
|
WO2020232029A1
(en)
|
2019-05-13 |
2020-11-19 |
Iovance Biotherapeutics, Inc. |
Methods and compositions for selecting tumor infiltrating lymphocytes and uses of the same in immunotherapy
|
|
US11950835B2
(en)
|
2019-06-28 |
2024-04-09 |
Virginia Tech Intellectual Properties, Inc. |
Cycled pulsing to mitigate thermal damage for multi-electrode irreversible electroporation therapy
|
|
US12214189B2
(en)
|
2019-07-24 |
2025-02-04 |
Virginia Tech Intellectual Properties, Inc. |
Fourier analysis spectroscopy for monitoring tissue impedance changes and treatment outcome during electroporation-based-therapies
|
|
EP4048295A1
(de)
|
2019-10-25 |
2022-08-31 |
Iovance Biotherapeutics, Inc. |
Genbearbeitung von tumorinfiltrierenden lymphozyten und deren verwendungen in der immuntherapie
|
|
US12516291B2
(en)
|
2019-12-11 |
2026-01-06 |
Iovance Biotherapeutics, Inc. |
Processes for the production of tumor infiltrating lymphocytes (TILs) and methods of using the same
|
|
CA3176826A1
(en)
|
2020-05-04 |
2021-11-11 |
Iovance Biotherapeutics, Inc. |
Processes for production of tumor infiltrating lymphocytes and uses of the same in immunotherapy
|
|
JP2023546359A
(ja)
|
2020-10-06 |
2023-11-02 |
アイオバンス バイオセラピューティクス,インコーポレイテッド |
腫瘍浸潤リンパ球療法によるnsclc患者の治療
|
|
WO2022076606A1
(en)
|
2020-10-06 |
2022-04-14 |
Iovance Biotherapeutics, Inc. |
Treatment of nsclc patients with tumor infiltrating lymphocyte therapies
|
|
US12485279B2
(en)
|
2020-11-25 |
2025-12-02 |
Virginia Tech Intellectual Properties, Inc. |
Methods for modulating temporal infrastructure of pulsed electric fields
|
|
AU2021401302A1
(en)
|
2020-12-17 |
2023-07-06 |
Iovance Biotherapeutics, Inc. |
Treatment with tumor infiltrating lymphocyte therapies in combination with ctla-4 and pd-1 inhibitors
|
|
EP4262827A1
(de)
|
2020-12-17 |
2023-10-25 |
Iovance Biotherapeutics, Inc. |
Behandlung von krebs mit tumorinfiltrierenden lymphozyten
|
|
WO2022165260A1
(en)
|
2021-01-29 |
2022-08-04 |
Iovance Biotherapeutics, Inc. |
Methods of making modified tumor infiltrating lymphocytes and their use in adoptive cell therapy
|
|
US20240191191A1
(en)
|
2021-03-19 |
2024-06-13 |
Iovance Biotherapeutics, Inc. |
Methods for infiltrating lymphocyte (til) expansion related to cd39/cd69 selection and gene knockout in tils
|
|
CA3213080A1
(en)
|
2021-03-23 |
2022-09-29 |
Krit RITTHIPICHAI |
Cish gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy
|
|
JP2024512029A
(ja)
|
2021-03-25 |
2024-03-18 |
アイオバンス バイオセラピューティクス,インコーポレイテッド |
T細胞共培養効力アッセイのための方法及び組成物、ならびに細胞療法製品との使用
|
|
CA3215830A1
(en)
|
2021-04-19 |
2022-10-27 |
Rafael CUBAS |
Chimeric costimulatory receptors, chemokine receptors, and the use of same in cellular immunotherapies
|
|
JP2024519029A
(ja)
|
2021-05-17 |
2024-05-08 |
アイオバンス バイオセラピューティクス,インコーポレイテッド |
Pd-1遺伝子編集された腫瘍浸潤リンパ球及び免疫療法におけるその使用
|
|
EP4373270A2
(de)
|
2021-07-22 |
2024-05-29 |
Iovance Biotherapeutics, Inc. |
Verfahren zur kryokonservierung von festen tumorfragmenten
|
|
JP2024527961A
(ja)
|
2021-07-28 |
2024-07-26 |
アイオバンス バイオセラピューティクス,インコーポレイテッド |
Kras阻害剤と併用した腫瘍浸潤リンパ球療法によるがん患者の治療
|
|
WO2023039488A1
(en)
|
2021-09-09 |
2023-03-16 |
Iovance Biotherapeutics, Inc. |
Processes for generating til products using pd-1 talen knockdown
|
|
WO2023077015A2
(en)
|
2021-10-27 |
2023-05-04 |
Iovance Biotherapeutics, Inc. |
Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy
|
|
CA3237410A1
(en)
|
2021-11-10 |
2023-05-19 |
Friedrich Graf Finck VON FINCKENSTEIN |
Methods of expansion treatment utilizing cd8 tumor infiltrating lymphocytes
|
|
EP4469065A1
(de)
|
2022-01-28 |
2024-12-04 |
Iovance Biotherapeutics, Inc. |
Zusammensetzungen und verfahren für cytokinassoziierte tumorinfiltrierende lymphozyten
|
|
WO2023196877A1
(en)
|
2022-04-06 |
2023-10-12 |
Iovance Biotherapeutics, Inc. |
Treatment of nsclc patients with tumor infiltrating lymphocyte therapies
|
|
JP2025512401A
(ja)
|
2022-04-15 |
2025-04-17 |
アイオバンス バイオセラピューティクス,インコーポレイテッド |
特定のサイトカインの組み合わせ及び/またはAKTi処理を使用したTIL拡張プロセス
|
|
CA3251533A1
(en)
|
2022-05-10 |
2023-11-16 |
Iovance Biotherapeutics, Inc. |
TREATMENT OF CANCER PATIENTS WITH TUMOR-INFILTRATING LYMPHOCYTE THERAPIES IN COMBINATION WITH AN IL-15R AGONIST
|
|
EP4583889A1
(de)
|
2022-09-09 |
2025-07-16 |
Iovance Biotherapeutics, Inc. |
Verfahren zur erzeugung von til-produkten mit pd-1/tigit talen-doppelknockdown
|
|
EP4583890A1
(de)
|
2022-09-09 |
2025-07-16 |
Iovance Biotherapeutics, Inc. |
Verfahren zur erzeugung von til-produkten mit pd-1/tigit talen-doppelknockdown
|
|
EP4612277A1
(de)
|
2022-11-04 |
2025-09-10 |
Iovance Biotherapeutics, Inc. |
Verfahren zur expansion von tumorinfiltrierenden lymphozyten (til) im zusammenhang mit cd39/cd103-auswahl
|
|
WO2024098024A1
(en)
|
2022-11-04 |
2024-05-10 |
Iovance Biotherapeutics, Inc. |
Expansion of tumor infiltrating lymphocytes from liquid tumors and therapeutic uses thereof
|
|
JP2025539816A
(ja)
|
2022-11-21 |
2025-12-09 |
アイオバンス バイオセラピューティクス,インコーポレイテッド |
腫瘍浸潤リンパ球の増幅のための2次元プロセス及びそれからの治療法
|
|
JP2025539712A
(ja)
|
2022-11-21 |
2025-12-09 |
アイオバンス バイオセラピューティクス,インコーポレイテッド |
遺伝子編集されたt細胞の増殖能を評価するための方法
|
|
WO2024118836A1
(en)
|
2022-11-30 |
2024-06-06 |
Iovance Biotherapeutics, Inc. |
Processes for production of tumor infiltrating lymphocytes with shortened rep step
|
|
WO2025054540A1
(en)
|
2023-09-08 |
2025-03-13 |
Iovance Biotherapeutics, Inc. |
Methods of gene-editing using programmable nucleases
|
|
WO2025101484A1
(en)
|
2023-11-06 |
2025-05-15 |
Iovance Biotherapeutics, Inc. |
Treatment of endometrial cancers with tumor infiltrating lymphocyte therapies
|
|
USD1084316S1
(en)
|
2023-11-20 |
2025-07-15 |
Angiodynamics, Inc. |
Ferrule
|